The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
Zahra KiamaneshNarjess AyatiRamin SadeghiEliza HawkesSze Ting LeeAndrew Mark ScottPublished in: European journal of nuclear medicine and molecular imaging (2022)
For anti-CD20 therapy of lymphoma, the MTV as a baseline <sup>18</sup>F-FDG PET/CT-derived parameter has the highest HRs for PFS and OS. The DS as visual criteria in early and late response assessment has higher HRs for PFS and OS compared to the international harmonization project (IHP) visual criteria in anti-CD20 therapy. Early changes in <sup>18</sup>F-FDG PET parameters may be predictive of response to ICIs and cell therapy in lymphoma patients.
Keyphrases
- cell therapy
- systematic review
- diffuse large b cell lymphoma
- end stage renal disease
- pet ct
- ejection fraction
- positron emission tomography
- chronic kidney disease
- stem cells
- pet imaging
- mesenchymal stem cells
- computed tomography
- meta analyses
- prognostic factors
- peritoneal dialysis
- quality improvement
- randomized controlled trial
- patient reported outcomes